作者: R. Berges , H. Schulze , T. Senge
DOI: 10.1007/978-3-642-84583-3_6
关键词: Endocrine therapy 、 Luteinizing hormone secretion 、 Medicine 、 Cyproterone acetate 、 Disease 、 Oncology 、 Androgen receptor 、 Advanced stage 、 Hormone 、 Internal medicine 、 Cancer
摘要: Even today, the majority of patients suffering from prostatic cancer have developed advanced stages disease at time diagnosis. In fact, 40% already suffer metastatic and a 50% risk dying within first 2 years after Although there is 50 experience hormonal treatment for prognosis still poor curative therapy not available.